Approved a new initial treatment for advanced non-small-cell lung cancer after clinical trials showed patients lived longer without disease progression, compared to the standard treatment currently used. The chemotherapy-free combination involves two drugs, one of which has never been approved for use in the U.S. called lazertinib, which will be...

FDA Approves New Treatment for Non-Small-Cell Lung Cancer

Invivyd’s investigational pemivibart (Pemgarda), which received an FDA emergency use authorization earlier this year, continued to show efficacy in preventing disease onset over a 6-month exploratory period in this patient population. In results reported today, topline data shows the monoclonal antibody, pemivibart, was highly efficacious in preventing the onset...

Monoclonal Antibody Reduces Symptomatic COVID-19 Risk by 84% in Immunocompromised

MP Biomedicals’ tests detect Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups O1 and O139. MP Biomedicals has introduced a new series of in vitro diagnostic tests that use immunochromatographic technology to detect gastrointestinal pathogens.The new kits focus on Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups O1 and O139. These diagnostic tools are designed to provide rapid and accurate results, enhancing the ability of healthcare professionals to detect and manage gastrointestinal infections.1.

Rapid Diagnostic Tests for Gastrointestinal Infectious Diseases

Reuters

(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Johnson & Johnson's chemotherapy-free combination treatment for a type of non-small cell lung cancer, setting up a challenge for AstraZeneca's blockbuster drug Tagrisso.

J&J's chemotherapy-free treatment for lung cancer gets US approval

FDA expands Omnipod 5 AID system for type 2 diabetes, marking the first AID system approved for both type 1 and type 2 diabetes management. The US Food and Drug Administration (FDA) has announced the expansion of indications for Insulet Corporation’s SmartAdjust technology, clearing the way for use of the Omnipod 5 Automated Insulin Delivery (AID) System in adults with type 2 diabetes.1.

FDA Clears Omnipod 5 AID System for Type 2 Diabetes

Cancer Health

In 2006, Diana Lindsay, who had never so much as held a cigarette, was diagnosed with stage 4 lung cancer. It had metastasized to both lungs, her brain and lymph nodes. Keith Eaton, MD, PhD, clinical director of thoracic, head and neck medical oncology at Fred Hutch Cancer Center, told her that a typical patient in this situation would have about nine months to live. But he also observed that she seemed remarkably strong and vital. “He said, ‘You don’t look like my normal lung cancer patient,’” said Lindsay, who had just returned from a business trip to Europe. She was 54 at the time. “He didn’t want to take away the health I had for the limited time I had to live.”

20 Years Since an EGFR Discovery, a Woman With Stage IV Lung Cancer Is Thriving

People may be at more risk of both AIDS and hepatitis B due to similar risk factors. Having HIV and hepatitis B may lead to serious complications. However, both are treatable and preventable. Stage 3 HIV is also known as AIDS. Stage 3 HIV is the most advanced stage of...

Stage 3 HIV (AIDS) and hepatitis B: What is the connection?

The following is a summary of “Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA),” published in the August 2024 issue of Neurology by Chisari et al. ‘Active’ and ‘non-active’ secondary progressive multiple sclerosis MS (SPMS) have...

Disease Progression in Active and Non-Active Secondary Progressive MS

Researchers have offered a comprehensive understanding of the progression of multiple myeloma from a treatable condition to a high-risk disease by providing insights into its genetic diversity and subtypes, according to a recent study published by Skerget et al in Nature Genetics. Background. Multiple myeloma is the second most common...

Novel Insights Into Multiple Myeloma Progression

Marouf Alhalabi ORCID: orcid.org/0000-0001-5027-20961 & Soumar Mueen Alziadan ORCID: orcid.org/0009-0000-3099-99331. Virology Journal volume 21, Article number: 188 (2024) Cite this article. Metrics details. Abstract. Background. The role of cytomegalovirus infection as an opportunistic pathogen in exacerbating ulcerative colitis and its response to treatment remain a topic of ongoing debate. Clinicians...

A diagnostic dilemma: cytomegalovirus colitis as an uncommon comorbidity in inflammatory bowel disease: a case report

Asking the right questions during visits with your doctor may help you get the information and support you need to manage your condition. Nonalcoholic steatohepatitis (NASH) is now known as metabolic dysfunction-associated steatohepatitis (MASH). This new name is more accurate and helps reduce the stigma associated with its older name.

7 Questions to Ask Your Doctor About Nonalcoholic Steatohepatitis (NASH)

An abnormal buildup of fat in the liver, referred to as fatty liver disease, was found to be common in a small group of children and adults with spinal muscular atrophy (SMA), regardless of their disease type or severity. Patient-derived liver cells confirmed that such accumulation was a result of...

Fatty liver disease may be common complication of SMA: Small study

Solly Chedid, MD, shares insights on optimizing anemia management in patients with lower-risk MDS and outlines remaining unmet needs in treating anemia. Case: Frontline Use of Erythroid Maturating Agent (EMA): Luspatercept. Clinical Presentation:. 70-year-old man diagnosed 6 months ago with LR-MDS with multilineage dysplasia - moderate anemia (Hb 11.2) and...

Key Takeaways and Unmet Needs in Lower-Risk MDS Anemia Management

A new study found hepatitis C virus reinfections may occur within 24 weeks of sustained virologic response after injecting drugs. A high rate of people who injected drugs had a hepatitis C virus (HCV) reinfection in the period immediately following sustained virologic response (SVR), a recent study found.1. “Rates of...

Injecting Drugs Often Leads to HCV Reinfection Which Reduces Over Time

A disease once known as nonalcoholic steatohepatitis or NASH is now called metabolic dysfunction-associated steatohepatitis or MASH; this is an inflammatory disorder that impairs the liver and causes scarring. The liver function of patients gets progressively worse, and the disease can lead to cirrhosis and liver cancer. One of the only treatment options is a liver transplant, which may not be available to all patients. The first treatment for the disease was only approved this year. Scientists have now learned more about the drivers of MASH, and how to determine if the disease is progressing or regressing in patients. The findings have been reported in the Proceedings of the National Academy of Sciences (PNAS).

A Name Change & New Insights for a Common Type of Liver Disease

Quiz: Test Your Knowledge on Chronic Hepatitis Research. What protein did researchers focus on in this study of chronic hepatitis?. Which cells in the liver were the main subject of this research?. What pathway did the researchers identify as key in regulating inflammation?. (Answers at the end of the article)

New Protein Target Could Lead to Better Treatments for Chronic Hepatitis

PiaSky (crovalimab) has previously been approved in countries such as the United States and Japan for monthly, subcutaneous use that may be self-administered with adequate training. Roche’s PiaSky (crovalimab) has been approved by the European Commission (EC) for certain patients with paroxysmal nocturnal hemoglobinuria (PNH), Roche announced in a press...

Paroxysmal Nocturnal Hemoglobinuria Treatment from Roche is Approved in EU

This is the first installment of a 6-part series on the management of polycystic ovary syndrome (PCOS). In this installment, Danielle R. Stratton, DNP, RN, PPCNP-BC, will discuss the basics of the syndrome and the psychosocial impact it can have from diagnosis to later life. Polycystic ovary syndrome (PCOS) is...

Polycystic Ovary Syndrome: Psychosocial Effects

On August 29, the Food and Drug Administration (FDA) approved Rybrevant (amivantamab) plus Lazcluze (lazertinib) as a chemotherapy-free initial regimen for people with locally advanced or metastatic non-small cell lung cancer (NSCLC) with specific mutations. The new combination is indicated for the treatment of NSCLC tumors with epidermal growth factor...

FDA Approves Chemo-Free Combo for Advanced Lung Cancer

Georgia State

Contributors represent independent, third-party users who have joined our contributor program and self-verified their accounts. They have also demonstrated their experience writing hard news for other outlets. Contributors are expected, like all users, to adhere to our Community Standards.

contributor

Atlanta, GA

Daily Coffee Press

A 40-year-old man has been sentenced to over 28 years in prison for distributing significant amounts of fentanyl and other controlled substances to dealers in the Middle Georgia region. Authorities revealed that investigators uncovered evidence linking the drugs provided by the defendant, 40-year-old Lagary Williams, also known as "Frog," from Atlanta, to a fatal overdose.

Atlanta Man Sentenced to 28 Years for Supplying Deadly Fentanyl Linked to Fatal Overdose

NewsBreak

New Data on Bemnifosbuvir's Progress in COVID-19 and HCV Trials

Atea pharmaceuticals' oral nucleotide RNA-dependent RNA polymerase inhibitor advances in phase 3 trials for COVID-19 and phase 2 trials for hepatitis C, showing potential efficacy. Atea...

New Data on Bemnifosbuvir's Progress in COVID-19 and HCV Trials

Comments / 0